Hei,
Liitteenä PEDEGO:n laiteinventaariolista. Ainoastaan yksi laite löytyy CRC:n tiloista, muut ovat ilmeisesti sairaalan puolella. Hoksaako kukaan teistä, että kuuluuko jokin näistä laitteista teidän ryhmälle?
Terv. Antti
Dive into the World of Cancer Biology - 5th CoMo Educational Symposium
Date: 27.10.2022
Place: Unioninkatu 35, Aud 116
Registration (open until 16:00 on 25.10.22): https://elomake.helsinki.fi/lomakkeet/118889/lomake.html
Program
9:00 Welcome words
Satu Kuure, GM-unit Coordinator, University of Helsinki
Session I
9:10 "Translational cancer biology: pro-metastatic mechanisms and CAR-T cell therapies"
Päivi Ojala, University of Helsinki
9:40 "Trunk neural crest enriched MOXD1 is a novel tumor suppressor gene in neuroblastoma"
Sophie Mohlin, Lund University
10:10 "Exploiting model organisms to interrogate ALK signaling in neuroblastoma"
Ruth Palmer, Göteborg University, Sweden
10:40 Coffee
11:00 "Targeting vulnerabilities in malignant brain tumous"
Pirjo Laakkonen, University of Helsinki
11:30 "Zebrafish core service introduction"
Henri Koivula, University of Helsinki
12:00 Lunch (included)
Session II
13:15-14:15 "How the Choice of Animal Model can Positively Affect the Reproducibility of Research"
Minttu-Maria Martikainen, Scanbur
14:15 "Systemic tumor homing peptides: identification and preclinical development for cancer imaging and therapy"
Tambet Teesalu, University of Tartu
15:00 Coffee
15:30 "Barriers to replicating preclinical cancer biology research - challenges or opportunities?"
Tim Errington, Center for Open Science, Charlottesville, United States (zoom)
16:15 "Culture change toward more open, rigorous, and reproducible research"
Brian Nosek, University of Virginia, Charlottesville, United States (zoom)
17:00 Closing remarks
Vootele Voikar, University of Helsinki
Organizers: Satu Kuure (satu.kuure at helsinki.fi) Vootele Voikar (vootele.voikar at helsinki.fi) and Pirjo Laakkonen
Dear all,
The full programme for the FibroHealth Symposium 2022<https://www.oulu.fi/en/events/fibrohealth-symposium-2022> is now published! We will have excellent speakers from our own University as well as external distinguished speakers.
The theme of the symposium is fibrosis and how it relates to health and disease.
What: FibroHealth Symposium 2022<https://www.oulu.fi/en/events/fibrohealth-symposium-2022>
When: 22 November 2022 at 12:00 - 15:55
Where: Lecture hall F101 at the Kontinkangas Campus, University of Oulu (Aapistie 7A)
Registration: The event is open to everyone. Please sign up by filling in this Webropol form<https://link.webropolsurveys.com/Participation/Public/942c4ad9-f253-458d-99…> to secure your catering.
[A group of pumpkins Description automatically generated with medium confidence]
Programme:
12.00-12.05 Welcome
Professor Johannes Kettunen, Biocenter Oulu, Faculty of Medicine
12.05-12.35 JAK kinases in health and disease
Professor Olli Silvennoinen, Helsinki Institute of Life Science, Institute of Biotechnology, the University of Helsinki (remotely)
12.35-12.55 The essential role of Th17/Treg cells in inflammation and fibrosis
Associate professor Zhi Jane Chen, Disease Networks research unit, Faculty of Biochemistry and Molecular Medicine, University of Oulu
12.55-13.25 Complement, fibroblasts, and matrix in invasion and metastasis of skin cancer
Professor Veli-Matti Kähäri, Department of Dermatology, University of Turku and Turku University Hospital
13.25-13.45 Prostate cancer cells losing the grip
Professor Aki Manninen, Biocenter Oulu Viral Gene Transfer laboratory, Disease Networks research unit, Faculty of Biochemistry and Molecular Medicine, University of Oulu
13.45-14.15 Coffee break
14.15-14.45 Myofibroblasts and Macrophages: A Touchy Subject
Professor Boris Hinz, St. Michael's Hospital and University of Toronto, Canada
14.45-15.05 Steps towards understanding FINCA: From rare to common brain and lung diseases
Associate professor Reetta Hinttala, Biocenter Oulu Transgenic and Tissue Phenotyping core facility, PEDEGO Research Unit, Faculty of Medicine, University of Oulu
15.05-15.35 Therapeutic perspectives for fibrosis in epidermolysis bullosa
Professor Leena Bruckner-Tuderman, Dept. of Dermatology, Medical Center, University of Freiburg, Germany
15.35-15.55 Brain electrohydrodynamics - novel findings, diagnostics, and treatment openings
Professor Vesa Kiviniemi, Department of Diagnostic Radiology, Oulu University Hospital; Research Unit of Medical Imaging, Physics, and Technology, Faculty of Medicine, University of Oulu
15.55-16.30 Casula networking session with refreshments and snacks
The event is co-organized by Profi6 Fibrobesity Research Programme and Biocenter Oulu.
Welcome!
On behalf of the organizing team,
Essi Erkkilä
---------------------------------------------------------------------------------------
Essi Erkkilä
Communications Specialist, Profi6 Fibrobesity
Research Unit for Internal Medicine (Room S5 224)
Faculty of Medicine
University of Oulu
tel. +358 50 521 5852
Twitter: FibroHealthOulu @FibroOulu
FibroHealth - Combatting Fibrosis in Chronic Diseases | University of Oulu<https://www.oulu.fi/en/fibrohealth-combatting-fibrosis-chronic-diseases>
[cid:image001.jpg@01D8E399.688CF7C0]
[In English below]
Suomen Akatemia avaa uuden yhteishaun National Institutes of Healthin (NIH) kanssa. Lisäksi on suunnitteilla yhteishaku National Science Foundationin (NSF) kanssa. Kuten aiemmissa yhteishauissa, myös nyt suunnitelluissa hauissa Suomi-Yhdysvallat -tutkimusyhteistyötä tuetaan Akatemian lippulaivojen edustamilla aihealueilla.
[https://www.sttinfo.fi/data/images/00288/1b043b27-77dc-4910-9cab-0cf56737e0…]
Uusia rahoitusmahdollisuuksia suunnitellaan Suomi-USA-tutkimusyhteistyöhön
18.10.2022 09:37:04 | Suomen Akatemia<https://www.sttinfo.fi/pressroom/suomenakatemia?publisherId=21481116>
Suomen Akatemia avaa uuden yhteishaun National Institutes of Healthin (NIH) kanssa. Lisäksi on suunnitteilla yhteishaku National Science Foundationin (NSF) kanssa. Kuten aiemmissa yhteishauissa, myös nyt suunnitelluissa hauissa Suomi-Yhdysvallat -tutkimusyhteistyötä tuetaan Akatemian lippulaivojen edustamilla aihealueilla.
Haut toteutetaan Lead Agency -mallilla. Siinä varsinainen yhteistyöhakemus jätetään NIH:n tai NSF:n järjestämään rahoitushakuun. Hakemuksen suomalaisosapuoli jättää hakemuksen rinnakkaisversion Akatemian verkkoasiointiin.
Suomi-Yhdysvallat -tutkimusyhteistyön rahoitusmahdollisuuksista kiinnostuneet ovat lämpimästi tervetulleita Suomen Akatemian ja FARIA-verkoston yhteiseen webinaariin 27.10.2022, klo 16.15 – 17.15<https://www.aka.fi/suomen-akatemian-toiminta/ajankohtaista/tapahtumat/acade…>.
Webinaarissa käydään läpi myös rahoituksen hakemisen erityispiirteitä, sillä yhteishaut eroavat toteutukseltaan merkittävästi Akatemian normaalista hakumenettelystä.
Suunnitellut uudet yhteishaut pohjautuvat Akatemian monipuoliseen ja jatkuvaan yhteistyöhön yhdysvaltalaiskumppaneiden kanssa. Rahoittajien välisen yhteistyön ja yhteishauissa rahoitettavien hankkeiden kautta Akatemia pyrkii merkittävästi edistämään suomalaisen tutkimuksen laatua, vaikuttavuutta ja uudistumista.
Lisätietoja
* Lue lisää Akatemian yhteistyöstä Yhdysvaltojen kanssa<https://www.aka.fi/suomen-akatemian-toiminta/mita-teemme/kansainvalinen-toi…>
* Lue lisää lippulaivaohjelmasta<https://www.aka.fi/tutkimusrahoitus/ohjelmat-ja-muut-rahoitusmuodot/lippula…>
* johtava tiedeasiantuntija Jukka Tanskanen, Suomen Akatemia, p. 029 533 5071
Sähköpostimme ovat muotoa etunimi.sukunimi(at)aka.fi.
Yhteyshenkilöt
[https://www.sttinfo.fi/data/images/00569/a5e76858-db0d-42eb-948e-5f956c2114…]
Anna Oravakangas
viestintäasiantuntija
Suomen Akatemia
www.aka.fi<http://www.aka.fi>
Puh:
0295 33 5039<tel:0295%2033%205039>
anna.oravakangas(a)aka.fi<mailto:anna.oravakangas@aka.fi>
[Twitter]<https://twitter.com/AnnaOravakangas>
Lisätietoa julkaisijasta Suomen Akatemia
Suomen Akatemia
Hakaniemenranta 6, PL 131
00531 HELSINKI
029 533 5000<tel:029%20533%205000>
http://www.aka.fi/fi
Suomen Akatemia rahoittaa korkealaatuista tieteellistä tutkimusta, toimii tieteen ja tiedepolitiikan asiantuntijana sekä vahvistaa tieteen ja tutkimustyön asemaa yhteiskunnassa. Pyrimme toiminnassamme siihen, että suomalainen tutkimus uusiutuu, monipuolistuu ja kansainvälistyy. Luomme edellytyksiä tutkijankoulutukselle ja tutkijanuralle, kansainvälistymiselle ja tutkimustulosten hyödyntämiselle. Katamme kaikki tieteen ja tutkimuksen alat. Vuonna 2022 rahoitamme tutkimusta 468 miljoonalla eurolla. Akatemia toimii opetus- ja kulttuuriministeriön hallinnonalalla.
[https://www.sttinfo.fi/data/images/00356/dd66710c-ceba-41a8-83a1-42627156fc…]
New funding opportunities in the pipeline for Finnish-US research cooperation
18.10.2022 09:37:49 | Suomen Akatemia<https://www.sttinfo.fi/pressroom/suomenakatemia?publisherId=21481116>
The Academy of Finland is set to open a new joint call with the National Institutes of Health (NIH). The Academy is also planning a joint call with the National Science Foundation (NSF). As in the previous Finnish-US joint calls, these new calls will support research cooperation in in research fields represented by the Academy-funded Finnish Flagships.
The calls will be implemented under the Lead Agency mechanism. Under the mechanism, a single collaboration proposal will be submitted to a funding call organised by the NIH or the NSF. Proposers from Finland will submit a version of the proposal to the Academy as well.
Parties interested in funding opportunities for Finnish-US research cooperation are welcome to join a webinar organised the Academy of Finland and the FARIA network on 27 October 2022 at 16.15–17.15<https://www.aka.fi/en/about-us/whats-new/events/updates-on-joint-calls-with…>.
The webinar will also examine the special features of applying for the funding, as the joint calls differ significantly from the Academy of Finland’s normal application procedures.
The planned joint calls are based on the Academy’s versatile and ongoing collaboration with its US partners. Through this funding agency cooperation and the projects funded in the joint calls, the Academy aims to significantly promote the quality, impact and renewal of Finnish research.
Inquiries and more information
* Read more about the Academy’s cooperation with the United States.<https://www.aka.fi/en/about-us/what-we-do/international-cooperation/global-…>
* Read more about the Finnish Flagship Programme.<https://www.aka.fi/en/research-funding/programmes-and-other-funding-schemes…>
* Jukka Tanskanen, Senior Science Adviser, Academy of Finland, tel. +358 295 335 071
Our email addresses are in the format firstname.lastname(at)aka.fi.
Contacts
[https://www.sttinfo.fi/data/images/00516/ea4d24ae-075f-4b38-b36e-257007da79…]
Anna Oravakangas
viestintäasiantuntija
Suomen Akatemia
www.aka.fi<http://www.aka.fi>
Tel:
0295 33 5039<tel:0295%2033%205039>
anna.oravakangas(a)aka.fi<mailto:anna.oravakangas@aka.fi>
[Twitter]<https://twitter.com/AnnaOravakangas>
About Suomen Akatemia
Suomen Akatemia
Hakaniemenranta 6, PL 131
00531 HELSINKI
029 533 5000<tel:029%20533%205000>
http://www.aka.fi/fi
The Academy of Finland funds high-quality scientific research, provides expertise in science and science policy, and strengthens the position of science and research in society. We work to contribute to the renewal, diversification and increasing internationalisation of Finnish research. We support and facilitate researcher training and research careers, internationalisation and the utilisation of research results. Our activities cover the full spectrum of scientific disciplines. In 2022, our funding for research amounts to 468 million euros. We are a government agency within the administrative branch of the Finnish Ministry of Education, Science and Culture.
Welcome to the Nordic Matchmaking Event for International Projects (especially Interreg Aurora and Interreg NPA)
Welcome to Rovaniemi, Finland on 16 - 17 November to meet new partners, catch up with old ones, and network with Nordic project partners.
Register now:
https://bit.ly/nordicmatchmaking<https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fbit.ly%2F…>
Program
Wednesday 16.11.
11.00 - 12.30 Registration
12.30 - 14.00 Plenary session: Opening words, Practical information, Lapland Region welcomes you, Greetings from Interreg Aurora and Interreg NPA
14.00 - 15.30 Thematic groups: Tourism and Culture, Circular Economy, Research and Innovation, Safety and Security, Energy Efficiency, Nature and Biodiversity, Climate Change Adaptation
15.30 - 18.00 Matchmaking: in person or online
18.00 - 18.30 Closing remarks Day 1
18.30 - Get-together
Thursday 17.11.2022
9.00 - 9.30 Registration
9.30 - 10.45 Plenary session: Practical information, Summaries of the Thematic groups, Launching new publication 'EU Project Planning and Management Handbook'
10.45 - 13.45 Matchmaking: in person or online, Project Clinics with Desk officers (Interreg Aurora and Interreg NPA)
13.45 -14.00 Closing remarks
Plenary sessions will be streamed for online participants. Thematic groups: in-person, online participation is also possible.
The event is organized by the KATOS project<https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fblogi.eop…> in collaboration with Interreg Aurora and Interreg Northern Periphery and Arctic programmes.
We would very much appreciate it if you could forward this invitation to your networks and anyone who could be interested in attending the event. Hope to see you in Rovaniemi!
On behalf of the organizers,
Eeva Helameri
Specialist, project planner
+358 (0) 40 6195662
eeva.helameri(a)lapinamk.fi<mailto:eeva.helameri@lapinamk.fi>
Vitality for Lapland by International RDI competence -project<https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fblogi.eop…>
Lapland University of Applied Sciences<https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.lapin…>
Jokiväylä 11, FI-96300 Rovaniemi, Finland<https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.googl…>
The Northern Factor
Welcome to 3rd FICAN Seminar!
The speaker is FCI K. Albin Johansson Foundation Research Professor Johanna Ivaska from Turku Bioscience Centre and University of Turku.
Topic: Cancer cells crossing borders
Time: Thursday November 3rd, 2022 at 15 -16 EEST
The seminar is organized in Teams and will be open to everyone who is interested in cancer research.
Click here to join the meeting<https://eur03.safelinks.protection.outlook.com/ap/t-59584e83/?url=https%3A%…> (note the passcode)
Meeting ID: 357 221 083 426
Passcode: j3ToWB
[Regional Cancer Centers]Time: Thu 3.11. at 15.00 - 16
Speaker: Johanna Ivaska, PhD, FCI K. Albin Johansson
Foundation Research Professor
Title: Cancer cells crossing borders
Get to know the Speaker: https://ivaskalab.utu.fi/<https://eur03.safelinks.protection.outlook.com/?url=https%3A%2F%2Fivaskalab…>
This time the seminar is organized by FICAN West
Abstract: Our research focuses on the fundamental role of cell-cell and cell-extracellular matrix crosstalk in maintaining tissue homeostasis. During tumour development, these pathways are altered and trigger the formation of environments that are physically and biochemically more conducive to cancer growth. Recently, we showed that expression of a motor protein MYO10, and MYO10-dependent filopodial extensions, while detrimental in invasive breast cancer and associated with poor patient survival, is protective at the early stage. In pre-invasive ductal carcinoma in situ (DCIS), MYO10 maintains a continuous basement-membrane border around the tumours and prevents dissemination into the surrounding stroma. Therefore, any therapeutic targeting of MYO10 must consider the dual actions of this motor protein and cancer stage. In another work (unpublished), we employed microfluidics to mimic cancer cell interaction with the vasculature (endothelial cell layer) under flow. We found that the method used by cancer cells to cross the endothelial cell barrier differs across cell types but is dependent on cancer-cell-endothelial-cell interaction, often involving the extension of filopodia-like protrusions. We are now employing single-cell mass CyToF and other innovative techniques to understand the molecular details of this interaction and identify a potential therapeutic target.
Relevant references for this talk:
E. Peuhu*, G. Jacquemet*, C. Scheele, A. Isomursu, M-C. Laisne, L.M. Koskinen, I. Paatero, K. Thol, M. Georgiadou, C. Guzmán, S. Koskinen, A. Laiho, L.L. Elo, P. Boström, P. Hartiala, J. van Rheenen, and J. Ivaska*. MYO10-filopodia support basement membranes at pre-invasive tumor boundaries. Developmental Cell (In Press). An earlier version available in the pre-print server bioRxiv. https://doi.org/10.1101/2021.10.22.464987<https://eur03.safelinks.protection.outlook.com/?url=https%3A%2F%2Fdoi.org%2…>.
Jacquemet G, Paatero I, Carisey AF, Padzik A, Orange JS, Hamidi H, Ivaska J. FiloQuant reveals increased filopodia density during breast cancer progression. J Cell Biol. 2017 Oct 2;216(10):3387-3403. doi: 10.1083/jcb.201704045.
Arjonen A, Kaukonen R, Mattila E, Rouhi P, Högnäs G, Sihto H, Miller BW, Morton JP, Bucher E, Taimen P, Virtakoivu R, Cao Y, Sansom OJ, Joensuu H, Ivaska J. Mutant p53-associated myosin-X upregulation promotes breast cancer invasion and metastasis. J Clin Invest. 2014 Mar;124(3):1069-82. doi: 10.1172/JCI67280.
_____________________________________
Mervi Toriseva, PhD
Institute of Biomedicine
and FICAN West Cancer Centre Laboratory
FICAN West Cancer Centre
University of Turku
Kiinamyllynkatu 10
Medisiina D, 5. floor
20520 TURKU
Finland
email: mailto:mervi.toriseva@utu.fi
Tiedoksi
Thelma Mäkikyrön säätiö sr julistaa haettavaksi 2-3 kpl enintään 15.000 euron suuruista tutkimusapurahaa sekä 2-3 kpl 2.000 euron suuruista matka-apurahaa. Säätiön hallitus varaa itselleen oikeuden jakaa apurahoja pienempiin osiin ylittämättä tässä ilmoituksessa mainittua enimmäiseuromäärää. Haettavien apurahojen yhteismäärä on enintään 51.000 euroa.
Apurahat on tarkoitettu edistämään syöpätautien tutkimusta. Apurahaa voivat hakea Pohjois-Suomessa tehtävää tutkimusta varten tutkijat ja tutkimusryhmät. Säätiö tukee erityisesti post doc -vaiheen tutkimusta.
Vapaamuotoiset hakemukset (4 kappaleena) toimitetaan viimeistään ma 14.11.2022 osoitteeseen:
Asiamies Ville Kestilä Rautatienkatu 50 A11, 90120 Oulu
Apurahahakemuksen enimmäissivumäärä on 5 sivua. Hakemukseen on oltava liitettynä lisäksi hakijan CV sekä julkaisuluettelo. Lisäksi hakemukseen on liitettävä hakijan yhteystiedot, joihin kuuluvat sähköpostiosoite, puhelinnumero sekä postiosoite.
Myönnetyistä apurahoista ilmoitetaan saajille henkilökohtaisesti kuluvan vuoden loppuun mennessä.
Lisätietoja antavat:
säätiön hallituksen puheenjohtaja, emeritusprofessori Martti Sorri, puh. +358 405 489 744, martti.sorri(a)oulu.fi<mailto:martti.sorri@oulu.fi>
säätiön asiamies Ville Kestilä, puh. +358 40 657 3722, ville.vk.kestila(a)pp1.inet.fi<mailto:ville.vk.kestila@pp1.inet.fi>
Thelma Mäkikyrön säätiön sr hallitus
Viestin välitti,
Katja Riipinen
Katja Riipinen
Tutkimuskoordinaattori, FT, TtK
Medical Research Center Oulu<https://www.oulu.fi/en/mrc> | MRC Oulu
Oulun yliopistollinen sairaala, Oulun yliopisto
OYS, Tutkimuspalvelut, N5 133
Puh. 08 315 4680, 050 448 4955
[cid:image003.jpg@01D8E21A.4490B170]
Multiple short-term doctoral researcher positions in the Health and Biosciences doctoral programme of the University of Oulu Graduate School<https://rekry.saima.fi/certiahome/open_job_view.html?did=5600&jc=1&id=00001…>
Apply for the job<https://rekry.saima.fi/certiahome/application_edit_welcome.html?field_id=0&…>
Full call text and link to apply the job:
https://rekry.saima.fi/certiahome/open_job_view.html?did=5600&jc=1&id=00001…
We are now looking motivated candidates for
Multiple short-term doctoral researcher positions
in the Health and Biosciences doctoral programme (HBS-DP) of the University of Oulu Graduate School (UniOGS<https://www.oulu.fi/en/research/graduate-school>).
HBS-DP gathers clinical medicine, biomedicine, biochemistry, molecular medicine, dentistry, health sciences and medical technology under the umbrella of a multidisciplinary training programme.
In the current call, there are multiple full-time short-term positions (3-6 months) and multiple full-time one year positions available in HBS-DP for 2023 (starting at the earliest on 1.1.2023 and ending the latest on 31.12.2023).
Please note that you can apply for either a one year or a short-term (3-6 months) position, but not both.
Eligibility and Requirements
As an eligible candidate, you have a Master’s degree or an equivalent degree in a field relevant to the applied field. The major subject of the doctoral researcher is expected to be in the Doctoral Degree Programme of Medicine, Biochemistry and Molecular Medicine, Health Sciences or Dentistry. The degree must have been completed before the selection with at least good grades. You must meet all the requirements to receive doctoral study rights as defined in: https://www.oulu.fi/en/research/graduate-school/admissions.
- In the short-term positions (3-6 months), the priority will be given to doctoral researchers working as a professional in the healthcare with a degree of Licentiate of Medicine, Licentiate of Dentistry or Master of Health Sciences.
- In the one year positions, priority will be given to such doctoral researchers whose supervisor’s research group is not receiving strategic funding (via focus institutes, emerging projects, doctoral programmes etc.) related to doctoral training from the University of Oulu during the funding period 2023. In the one year positions, any applicant who has received doctoral study rights on or earlier than 31.12.2019 need to explain why they should still be considered as eligible applicants and to assure the motivation for graduating during one year.
Prior to submitting, applicants are expected to find a prospective main supervisor in an eligible research unit. Applicants are advised to seek potential supervisors in the faculty web pages (https://www.oulu.fi/en/university/faculties-and-units). The proposed main supervisor must clearly be identified in the application form (full name, title, position, faculty and research unit at the University of Oulu). A letter from the proposed supervisor willing to commit for supervision must be attached into the applicant’s set of documents (see below).
Unless explicitly stated otherwise, the commitment letter does not bind the proposed supervisor to any commitment, if the applicant is not selected into the doctoral researcher position applied here and for which the letter of support was provided.
Salary and key terms
The salary will be initially set on level 2, and later on levels 2 – 4 of the national salary scale for the teaching and research staff of Finnish universities. In addition, a supplementary remuneration is given for personal achievement and performance (max. 50 %). In practice, the salary is roughly 2200 – 2700 € per month for an early stage researcher, depending on the appointee’s qualifications and progress of the doctoral thesis.
The positions are filled earliest in the beginning of 2023 and ending the latest at December 31, 2023. A trial period is applied to these positions with maximum length being half of the employment period.
How to apply
Submit your application and attachments in English (with exceptions for Certificates/Diplomas) through the online system by 16th of October, 2022 (23:59 Finnish local time). Please include the following attachments as five separate pdf files (please note that the online system has a maximum size limit for attachments):
1. CV: Including a list of all peer-reviewed scientific publications with full reference details following the guidelines of the Finnish Advisory Board on Research Integrity: http://www.tenk.fi/en/template-researchers-curriculum-vitae
2. Motivation letter: Describing prior knowledge, research interests and career plan (max 1 page).
3. Certificates/Diplomas: Scanned electronic copies of diplomas and transcripts of the records of relevant previous degrees. If the original documents are not in Finnish, Swedish or English, each document must be accompanied by an official certified translation into Finnish or English.
4. Research plan approved by the supervisor: Please follow the structure given in the guidelines of the Academy of Finland (https://www.aka.fi/en/research-funding/apply-for-funding/how-to-apply-for-f…) However, for the current purpose, the texts under the given section headings need not cover all bullet points in the guidelines, and the maximum length of the (draft) plan’s body of text must not exceed 3 pages with 10-12 point font size and with at least 1,5 cm margins. A fourth page can be used for the list of references only. Thus, the max total length of the plan including the references is 4 pages. Exceeding the page limit will either result in disqualification or removal of the extra pages from the document.
5. Letter of provisional commitment from the supervisor (the pre-formulated<https://unioulu-my.sharepoint.com/:w:/g/personal/misalo_univ_yo_oulu_fi/EVM…> form that must be used): In this document the eligible supervisor (either a professor or a docent level researcher who is employed by the University of Oulu) states his/her willingness to act as the supervisor for the applicant. Commitment letter must include the provisional supervisor’s assurance that the research unit director is aware of and committed to the financial obligations related to these positions. The University will cover only part of the costs related to this position and the unit will cover the rest. Typically, 20-35% of the salary and sidecosts remain to be covered by research unit. All other other costs are to be covered by research unit.
Applications received after the deadline, incomplete applications, and/or applications with attachments that exceed the specified limits, will not be considered.
Application and evaluation process
Evaluation and ranking of the applications will take place in multiple stages. First, ineligible or incomplete applications are rejected. Second, eligible and complete applications are evaluated and ranked by the evaluation panel. Third, applications with highest scores from the second round will be further evaluated and ranked by the corresponding Doctoral Training Committee. All applicants will be informed of the selection by e-mail.
Further information
About eligibility and degree requirements, see the Graduate School website:
https://www.oulu.fi/en/research/graduate-school
About the evaluation process: HBS-DP coordinator Mirja Peltola (firstname.lastname(a)oulu.fi<mailto:firstname.lastname@oulu.fi>).
Apply for the job<https://rekry.saima.fi/certiahome/application_edit_welcome.html?field_id=0&…>
Feel free to distribute this announcement further!
Best wishes,
Mirja
------------------------------------------------------------------------------------------------------
Mirja Peltola, PhD, BSc (Tech.)
Koordinaattori | Coordinator
Oulun yliopisto | University of Oulu
Terveys- ja biotieteiden tohtoriohjelma | Health and Biosciences Doctoral Programme
Tel. 0294 48 5447
PO Box 5000, FI-90014 OULUN YLIOPISTO
(Aapistie 5A, Room 476B)
www.oulu.fi<http://www.oulu.fi/yliopisto>
www: Terveys- ja biotieteiden tohtoriohjelma | Health and Biosciences Doctoral Programme<https://www.oulu.fi/en/science-arctic-attitude/graduate-school/organisation…>